These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9603161)

  • 21. Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model.
    Fechner JH; Vargo DJ; Geissler EK; Wang J; Neville DM; Knechtle SJ
    Transplant Proc; 1997; 29(1-2):1158. PubMed ID: 9123249
    [No Abstract]   [Full Text] [Related]  

  • 22. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
    Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological tolerance as an adjunct to allogeneic tissue grafting.
    Thomas F; Ray P; Thomas JM
    Microsurgery; 2000; 20(8):435-40. PubMed ID: 11150996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new reagent for the induction of T-cell depletion, anti-CD3-CRM9.
    Neville DM; Scharff J; Hu HZ; Rigaut K; Shiloach J; Slingerland W; Jonker M
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):85-92. PubMed ID: 8732691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depletion of T lymphocytes with immunotoxin retards the progress of experimental allergic encephalomyelitis in rhesus monkeys.
    Hu H; Stavrou S; Cairns Baker B; Tornatore C; Scharff J; Okunieff P; Neville DM
    Cell Immunol; 1997 Apr; 177(1):26-34. PubMed ID: 9140093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of the humoral response induced by an anti-CD3 monoclonal antibody by deoxyspergualin in a murine model.
    Alegre ML; Sattar HA; Herold KC; Smith J; Tepper MA; Bluestone JA
    Transplantation; 1994 Jun; 57(12):1786-94. PubMed ID: 8016885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.
    Kirk AD; Mannon RB; Kleiner DE; Swanson JS; Kampen RL; Cendales LK; Elster EA; Wakefield T; Chamberlain C; Hoffmann SC; Hale DA
    Transplantation; 2005 Oct; 80(8):1051-9. PubMed ID: 16278585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells.
    Lehmann M; Graser E; Risch K; Hancock WW; Müller A; Kuttler B; Hahn HJ; Kupiec-Weglinski JW; Brock J; Volk HD
    Transplantation; 1997 Oct; 64(8):1181-7. PubMed ID: 9355837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immune decision toward allograft tolerance in non-human primates requires early inhibition of innate immunity and induction of immune regulation.
    Hutchings A; Wu J; Asiedu C; Hubbard W; Eckhoff D; Contreras J; Thomas FT; Neville D; Thomas JM
    Transpl Immunol; 2003; 11(3-4):335-44. PubMed ID: 12967786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
    Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
    Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids.
    Fechner JH; Dong Y; Hong X; Brunner KG; Tsuchida M; Neville D; Scharff J; Lee F; Oberley TD; Peters D; Schultz JM; Manthei ER; Hamawy MM; Knechtle SJ
    Transplantation; 2001 Aug; 72(4):581-7. PubMed ID: 11544415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effects of cyclic administration of 15-deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis.
    Kälsch AI; Schmitt WH; Breedijk A; Marinaki S; Weigerding S; Nebe TC; Nemoto K; van der Woude FJ; Yard BA; Birck R
    Clin Exp Immunol; 2006 Dec; 146(3):455-62. PubMed ID: 17100765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice.
    Forster K; Goethel A; Chan CW; Zanello G; Streutker C; Croitoru K
    Gastroenterology; 2012 Nov; 143(5):1298-1307. PubMed ID: 22819863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms of CD3epsilon in cynomolgus and rhesus monkeys and their relevance to anti-CD3 antibodies and immunotoxins.
    Liu YY; Wang Z; Thomas J; Goodwin KJ; Stavrou S; Neville DM
    Immunol Cell Biol; 2007 Jul; 85(5):357-62. PubMed ID: 17325695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
    Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
    Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STEALTH matters: a novel paradigm of durable primate allograft tolerance.
    Thomas JM; Hubbard WJ; Sooudi SK; Thomas FT
    Immunol Rev; 2001 Oct; 183():223-33. PubMed ID: 11782260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
    Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
    Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunosuppressive agent 15-deoxyspergualin functions by inhibiting cell cycle progression and cytokine production following naive T cell activation.
    Holcombe H; Mellman I; Janeway CA; Bottomly K; Dittel BN
    J Immunol; 2002 Nov; 169(9):4982-9. PubMed ID: 12391212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pre-existing anti-diphtheria toxin antibodies on T cell depletion levels following diphtheria toxin-based recombinant anti-monkey CD3 immunotoxin treatment.
    Matar AJ; Pathiraja V; Wang Z; Duran-Struuck R; Gusha A; Crepeau R; Tasaki M; Sachs DH; Huang CA
    Transpl Immunol; 2012 Aug; 27(1):52-4. PubMed ID: 22676970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.